Affiliation:
1. Kamuzu Central Hospital
2. Malawi-Liverpool-Wellcome Trust Clinical Research Programme
3. Blantyre Adventist Hospital
4. Kamuzu University of Health Sciences
5. Queen Elizabeth Central Hospital
6. The University of North Carolina Project-Lilongwe
Abstract
Abstract
Background
Dyslipidaemia among individuals with diabetes is a significant modifiable risk factor for atherosclerotic cardiovascular diseases (ASCVDs). ASCVDs are a major cause of mortality and morbidity globally, especially in people with diabetes. In Malawi, limited data exist on the prevalence and biochemical characteristics of diabetic dyslipidaemia. This study investigated the prevalence and biochemical characteristics of dyslipidaemia in individuals attending the diabetes clinic at Kamuzu Central Hospital, the largest tertiary referral hospital in Central Malawi.
Methods
Using a cross-sectional design, sociodemographic, medical and anthropometric data were collected from 391 adult participants who were enrolled in the study. Blood samples were analysed for glycosylated haemoglobin (HBA1c) and fasting lipid profiles. The prevalence of dyslipidaemia was calculated, and the biochemical characteristics of the dyslipidaemia were defined. The associations between dyslipidaemia and risk factors such as sociodemographic characteristics, obesity, and HBA1c levels were evaluated using logistic regression analysis.
Results
Prevalence of dyslipidaemia was observed in 71% of the participants, and elevated low-density lipoprotein cholesterol was the most frequent lipid abnormality among the study participants. On bivariate analysis, dyslipidemia was positively associated with female sex [OR 1.65 (95% CI 1.05–2.58); p = 0.09], age ≥ 30 years [OR 3.60 (95% CI 1.17–7.68); p = 0.001] and overweight and obesity [OR 2.11 (95% CI 1.33–3.34); p = 0.002]. On multivariate analysis, being overweight or obese was an independent predictor of dyslipidaemia [AOR 1.8 ;( 95% CI 1.15–3.37); p = 0.04].
Conclusion
Dyslipidaemia was highly prevalent among individuals with diabetes in this study, and elevated low-density lipoprotein cholesterol was the most frequent lipid abnormality. Overweight and obesity were also highly prevalent and positively predicted dyslipidaemia. This study highlights the importance of appropriately addressing dyslipidaemia, overweight and obesity among individuals with diabetes in Malawi and other similar settings in Africa as one of the significant ways of reducing the risk of ASCVDs among this population.
Publisher
Research Square Platform LLC
Reference42 articles.
1. Federation ID. IDF Diabetes Atlas Brussels. Belgium: International Diabetes Federation; 2021.
2. Knoema. Malawi - Diabetes prevalence as a share of population aged 20–79 years 2021 [updated 2023; cited 2023 February ]. Available from: https://knoema.com/atlas/Malawi/topics/Health/Nutrition/Diabetes-prevalence.
3. Dyslipidaemia pattern and prevalence among type 2 diabetes mellitus patients on lipid-lowering therapy at a tertiary hospital in central South Africa;Pitso L;BMC Endocr Disorders,2021
4. Prevalence of dyslipidaemia among adults in Africa: a systematic review and meta-analysis;Noubiap JJ;The Lancet Global Health,2018
5. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study;Roth GA;J Am Coll Cardiol,2020